Metabolon: Funding, Investors & Team (Sep 2026)
Metabolon is a technology company that specializes in developing analytical methods and software for biomarker discovery through metabolomics. Their expertise in data and translational science allows them to help customers and partners address complex questions in the life sciences, speeding up research and improving outcomes. They offer customizable multiomics solutions, including metabolomics and lipidomics, to support customers from discovery to clinical trials and beyond. Metabolon aims to provide biochemical data and insights that enhance the impact of life sciences research and seamlessly integrate with other 'omics' technologies.
Metabolon has raised $60.0M across 1 funding round on record, the most recent an undisclosed round of $60.0M announced in May 2024.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Metabolon Company Profile and Key Stats
Latest funding round on record: May 2024.
Metabolon Funding Rounds
Metabolon Founders and Leadership Team
No contact details are on record for this team yet.
Metabolon Funding Compared to Other Biotechnology Startups
Metabolon's latest round of $60.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Metabolon in Biotechnology and Morrisville
Companies Similar to Metabolon
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Paterna BioSciences, Inc. is a pioneering biotechnology company dedicated to solving the significant…
Legendary Bio's solidarity is a determined spotlight on introducing another period of quality guideline.
Cataract surgery is the single most common procedure performed in the United States annually. Despite…
InSitu Biologics is a developer of a drug delivery platform designed to focus on development of new and…
Remedium Bio is a gene therapy company in the Boston area that is dedicated to developing cures for severe…
Metabolon Funding FAQs
What does Metabolon do?
Metabolon is a technology company that specializes in developing analytical methods and software for biomarker discovery through metabolomics. Their expertise in data and translational science allows them to help customers and partners address complex questions in the life sciences, speeding up research and improving outcomes. They offer customizable multiomics solutions, including metabolomics and lipidomics, to support customers from discovery to clinical trials and beyond. Metabolon aims to provide biochemical data and insights that enhance the impact of life sciences research and seamlessly integrate with other 'omics' technologies.
How much funding has Metabolon raised?
Metabolon has raised $60.0M across 1 round on record. The most recent is an undisclosed round of $60.0M announced in May 2024.
When did Metabolon last raise funding?
Metabolon's most recent funding round on record is an undisclosed round of $60.0M, announced in May 2024.
Who founded Metabolon?
FundedIQ lists Lisa Millet (Founder) at Metabolon.
Where is Metabolon headquartered?
Metabolon is based in Morrisville, North Carolina, United States.
How many employees does Metabolon have?
Metabolon is in the 251-500 employee band.
How does Metabolon's funding compare to other Biotechnology startups?
Metabolon's latest round of $60.0M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Metabolon Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Metabolon is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.